Carthera Is A Clinical Stage Medtech Company Based In Lyonfrancewith Additional Offices In Paris And A Subsidiary In The Usfounded In 2010 By Professor Alexandre Carpentierthe Company Focuses On Developing Ultrasound Based Medical Devices To Treat Severe Brain Disordersparticularly Glioblastoma And Other Central Nervous System Diseases The Flagship Productsonocloudis An Intracranial Implant That Uses Low Intensity Pulsed Ultrasound To Temporarily Open The Blood Brain Barrierthis Technology Enhances The Delivery Of Chemotherapy Drugs To Brain Tumorsaddressing Significant Challenges In Glioblastoma Treatmentcarthera Has Conducted Clinical Trials Demonstrating The Safety And Efficacy Of Sonocloudwith Ongoing Studies To Validate Long Term Outcomesthe Company Collaborates With Academic Institutions And Industry Leaders To Advance Its Ultrasound Based Therapies And Continues To Explore Applications For Other Cns Diseases
